The status of measles after five years of mass vaccination in the USSR
- PMID: 4548384
- PMCID: PMC2481016
The status of measles after five years of mass vaccination in the USSR
Abstract
Mass vaccination of children from 10 months to 8 years old with the original live vaccine prepared from the Leningrad-16 strain has led to a sharp decline in measles morbidity and mortality, and changed its epidemic pattern. In 1972, after 5 years of mass vaccination, the morbidity rate was 117.5 per 100 000 persons, whereas before vaccination the average annual morbidity rate was about 827.0. The periodicity of increases in morbidity every 3 years was also broken, the last peak of measles morbidity occurring in 1965. Another result of vaccination is that the formerly much higher morbidity rate in urban areas is now lower than that in rural areas. The mortality rate decreased more than 3-fold compared with the period before vaccination, and recently no deaths were registered in a number of regions. The serologic examination of 7 585 vaccinated children from 10 different regions revealed antibodies with a mean geometric titre of 78.6+/-1.16 in 90% of individuals. The high antibody level was maintained for 7 years after vaccination. The effect of vaccination is both epidemiological and economical. The saving in the use of gamma-globulin alone covered the cost of the vaccine and the expenses involved during vaccination.
Similar articles
-
[Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].Zhonghua Yi Xue Za Zhi. 1989 Jul;69(7):389-91. Zhonghua Yi Xue Za Zhi. 1989. PMID: 2598095 Chinese. No abstract available.
-
Revaccination against measles--a pilot study.J R Coll Gen Pract. 1975 Dec;25(161):863-73. J R Coll Gen Pract. 1975. PMID: 1223275 Free PMC article.
-
Measles susceptibility in two Pacific atoll populations. Epidemiological factors and response to live attenuated measles virus.Med J Aust. 1974 May 18;1(20):789-93. Med J Aust. 1974. PMID: 4853112 No abstract available.
-
[Status of immunity after measles vaccination (author's transl)].Ann Sclavo. 1980 Jul-Aug;22(4):545-54. Ann Sclavo. 1980. PMID: 7018418 Review. Italian. No abstract available.
-
Measles vaccines.Br Med Bull. 1969 May;25(2):153-8. doi: 10.1093/oxfordjournals.bmb.a070685. Br Med Bull. 1969. PMID: 4918530 Review. No abstract available.
Cited by
-
Chapter 8 Paramyxoviruses.Perspect Med Virol. 1985;1:345-404. doi: 10.1016/S0168-7069(08)70016-8. Epub 2008 May 29. Perspect Med Virol. 1985. PMID: 32336840 Free PMC article.
-
Vaccine platform recombinant measles virus.Virus Genes. 2017 Oct;53(5):733-740. doi: 10.1007/s11262-017-1486-3. Epub 2017 Jul 14. Virus Genes. 2017. PMID: 28710608 Free PMC article. Review.
-
Cost-benefit analysis and immunization programmes in developing countries.Bull World Health Organ. 1980;58(3):491-7. Bull World Health Organ. 1980. PMID: 6774825 Free PMC article.
References
-
- J Trop Med Hyg. 1970 Aug;73(8):183-5 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources